A Quote by Tony Blair

...we must support and protect individuals and companies engaged in life saving medical research — © Tony Blair
...we must support and protect individuals and companies engaged in life saving medical research
We have a lot to gain through furthering stem cell research, but medical breakthroughs should be fundamentally about saving, not destroying, human life. Therefore, I support stem cell research that does not destroy the embryo.
Drug companies spend more on advertising and marketing than on research, more on research on lifestyle drugs than on life saving drugs, and almost nothing on diseases that affect developing countries only. This is not surprising. Poor people cannot afford drugs, and drug companies make investments that yield the highest returns.
A lot of insurance companies don't protect transgender people because they think it's medically unnecessary, but we deserve to be covered, and this is life-saving treatment.
If Christianity has really come from heaven, it must renew the whole life of man; it must govern the life of nations no less than that of individuals; it must control a Christian when acting in his public and political capacity as completely as when he is engaged in the duties which belong to him as a member of a family circle.
It is ironic that in the same year we celebrate the 50th anniversary of the discovery of DNA, some would have us ban certain forms of DNA medical research. Restricting medical research has very real human consequences, measured in loss of life and tremendous suffering for patients and their families.
I decided to take two years between finishing undergraduate and beginning medical school to devote fully to medical research. I knew that I wanted to go to medical school during undergraduate, but I was also eager to get a significant amount of research experience.
Millions of American families affected by debilitating diseases have new hope today after the U.S. House passed legislation to support potentially life-saving stem cell research.
Americans broadly consent to funding clinical research because they believe in the promise of medical research. But people support scientific work only if they trust that it serves societal interests, respects patient dignity and operates with guardrails.
Some of the power has shifted from companies to people. Using social media tools (blogs, wikis, tagging, etc.) more individuals are creating semi-spontaneous 'groundswells' of opinions to which companies and other institutions are realizing they must respond. From marketing to consumers organizations are being pulled into engaging with individuals.
Drug companies should not be allowed to reap excessive profits or spend unreasonable amounts on marketing if they want to receive support that is designed to encourage life- saving and health-improving treatments.
Don't assume that the way that one searches and researches is the same from one era to another - it isn't. In the 19th century, most research was done by amateurs: either individuals who were rich or individuals who had a day job. In the 20th century, most researchers worked at universities or think tanks and received money from the government or from foundations to pursue their work. In our time, the sources of support and the locations for research may be quite different.
We do all that [ represent companies], because we have a lot of research in Japanese companies, and that research educates investors around the world. It allows us to sell stocks and bonds in Japanese companies.
The field of U.S. cancer care is organized around a medical monopoly that ensures a continuous flow of money to the pharmaceutical companies, medical technology firms, research institutes, and government agencies such as the Food and Drug Administration (FDA) and the National Cancer Institute (NCI) and quasi-public organizations such as the American Cancer Society (ACS).
To ensure that America remains the leader in medical innovation, we must reduce the costs of developing life-saving drugs and ensure that there are appropriate economic incentives in place to produce them.
Government support is not only investing in upstream areas like basic research, but also in downstream areas like applied research and early-stage financing for the companies themselves. This means there are great risks.
Needless to say, I fully support the legal codes that are meant to protect individuals from discrimination.
This site uses cookies to ensure you get the best experience. More info...
Got it!